Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 30

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1B
Chunk 30
---
 Award Agreement under the 2011 Equity Incentive Plan.
     
    10-K
     
    001-14895
     
    10.18
     
    2/28/17

     10.6†
     
    Sarepta Therapeutics, Inc. Amended and Restated 2013 Employee Stock Purchase Plan.
     
    8-K
     
    001-14895
     
    10.2
     
    7/1/16

     10.7†
     
    Sarepta Therapeutics, Inc. 2014 Employment Commencement Incentive Plan, as amended.
     
    S-8
     
    001-14895
     
    4.4
     
    2/25/16

     10.8†
     
    Form of Stock Option Award Agreement under 2014 Employment Commencement Incentive Plan
     
    10-K
     
    001-14895
     
    10.28
     
    3/3/14

     10.9*
     
    Amended and Restated Exclusive License Agreement by and among The University of Western Australia, Sarepta Therapeutics, Inc., and Sarepta International CV dated April 10, 2013.
     
    10-Q
     
    001-14895
     
    10.1
     
    5/9/13

     10.10*
     
    First Amendment to License Agreement by and among The University of Western Australia, Sarepta Therapeutics, Inc., and Sarepta International CV dated June 19, 2016.
     
    10-Q
     
    001-14895
     
    10.1
     
    8/9/16

     10.11†
     
    Amendment No. 1 to the Sarepta Therapeutics, Inc. Amended and Restated 2011 Equity Incentive Plan
     
    8-K
     
    001-14895
     
    10.1
     
    6/30/15

     10.12
     
    Asset Purchase Agreement dated February 20, 2017 by and between Sarepta Therapeutics Inc. and Gilead